Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

NCT01216683 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

289

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: Bendamustin
DRUG: bortezomib
DRUG: lenalidomide

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]